Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: Two-polarized roles of transcription factor FOSB in lung cancer progression and prognosis: dependent on p53 status

Fig. 1

FOSB expression predicted opposite prognoses between LUAD and LUSC (A) FOSB mRNA expression profile in the NSCLC cohort, of which the data were obtained from the TCGA database; (B) FOSB protein expression levels in NSCLC tissues, of which the data were obtained from THE HUMAN PROTEIN ATLAS database; (C) FOSB mRNA expression levels in collected NSCLC tissues, detected by real-time quantitative PCR (RT-qPCR); (D) Representative immunoreactive bands of FOSB protein expression levels in collected NSCLC tissues, detected by Western Blot; (E) Quantitative analysis of the immunoreactive bands displayed in (D); (F) FOSB mRNA expression levels in NSCLC cell lines, detected by RT-qPCR; (G) Representative immunoreactive bands of FOSB protein expression levels in NSCLC cell lines, detected by Western Blot; (H) Quantitative analysis of the immunoreactive bands displayed in (G); (I) Kaplan-Meier survival curves (OS) of FOSB expression in the NSCLC cohort, of which the data were obtained from the TCGA database. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001

Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us